Coexpression cluster:C184: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(5 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 10:51, 17 September 2013
Full id: C184_somatostatinoma_smallcell_nonsmall_small_gastrointestinal_pineal_thyroid
Phase1 CAGE Peaks
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
No results for this coexpression
Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0031716 | calcitonin receptor binding | 0.0137489753507221 |
GO:0033588 | Elongator holoenzyme complex | 0.0137489753507221 |
GO:0001984 | vasodilation of artery during baroreceptor response to increased systemic arterial blood pressure | 0.0137489753507221 |
GO:0001983 | baroreceptor response to increased systemic arterial blood pressure | 0.0137489753507221 |
GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity | 0.0137489753507221 |
GO:0050961 | detection of temperature stimulus during sensory perception | 0.0137489753507221 |
GO:0045932 | negative regulation of muscle contraction | 0.0137489753507221 |
GO:0050965 | detection of temperature stimulus during sensory perception of pain | 0.0137489753507221 |
GO:0045986 | negative regulation of smooth muscle contraction | 0.0137489753507221 |
GO:0043195 | terminal button | 0.0137489753507221 |
GO:0004406 | H3/H4 histone acetyltransferase activity | 0.0137489753507221 |
GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity | 0.0137489753507221 |
GO:0001978 | carotid sinus baroreceptor feedback regulation of systemic arterial blood pressure | 0.0137489753507221 |
GO:0033267 | axon part | 0.0137489753507221 |
GO:0016048 | detection of temperature stimulus | 0.0137489753507221 |
GO:0050951 | sensory perception of temperature stimulus | 0.0137489753507221 |
GO:0003025 | baroreceptor regulation of systemic arterial blood pressure | 0.0137489753507221 |
GO:0016021 | integral to membrane | 0.0137489753507221 |
GO:0031224 | intrinsic to membrane | 0.0137489753507221 |
GO:0048265 | response to pain | 0.0137489753507221 |
GO:0003085 | negative regulation of systemic arterial blood pressure | 0.0137489753507221 |
GO:0008607 | phosphorylase kinase regulator activity | 0.0137489753507221 |
GO:0002027 | regulation of heart rate | 0.0139590597962431 |
GO:0051482 | elevation of cytosolic calcium ion concentration during G-protein signaling, coupled to IP3 second messenger (phospholipase C activating) | 0.0139590597962431 |
GO:0045778 | positive regulation of ossification | 0.0139590597962431 |
GO:0016944 | RNA polymerase II transcription elongation factor activity | 0.0139590597962431 |
GO:0031645 | negative regulation of neurological process | 0.0151207568562064 |
GO:0046852 | positive regulation of bone remodeling | 0.0151207568562064 |
GO:0001976 | regulation of systemic arterial blood pressure by neurological process | 0.0156069152171386 |
GO:0045776 | negative regulation of blood pressure | 0.0156069152171386 |
GO:0030279 | negative regulation of ossification | 0.0156069152171386 |
GO:0044425 | membrane part | 0.0201527026644171 |
GO:0046851 | negative regulation of bone remodeling | 0.0201527026644171 |
GO:0033555 | multicellular organismal response to stress | 0.0207263588466125 |
GO:0008023 | transcription elongation factor complex | 0.0207263588466125 |
GO:0009408 | response to heat | 0.0218275968006529 |
GO:0019233 | sensory perception of pain | 0.0244999460665658 |
GO:0007202 | phospholipase C activation | 0.0247905539309607 |
GO:0003073 | regulation of systemic arterial blood pressure | 0.0247905539309607 |
GO:0003711 | transcription elongation regulator activity | 0.0271865372509221 |
GO:0042311 | vasodilation | 0.0273275662456433 |
GO:0030278 | regulation of ossification | 0.0273275662456433 |
GO:0006940 | regulation of smooth muscle contraction | 0.0280939917086146 |
GO:0007190 | adenylate cyclase activation | 0.0301823823024857 |
GO:0046850 | regulation of bone remodeling | 0.0301823823024857 |
GO:0051241 | negative regulation of multicellular organismal process | 0.0301823823024857 |
GO:0031644 | regulation of neurological process | 0.0301823823024857 |
GO:0004468 | lysine N-acetyltransferase activity | 0.0301823823024857 |
GO:0004402 | histone acetyltransferase activity | 0.0301823823024857 |
GO:0051349 | positive regulation of lyase activity | 0.0301823823024857 |
GO:0045762 | positive regulation of adenylate cyclase activity | 0.0301823823024857 |
GO:0031281 | positive regulation of cyclase activity | 0.0301823823024857 |
GO:0009266 | response to temperature stimulus | 0.0330195727456264 |
GO:0006493 | protein amino acid O-linked glycosylation | 0.0335221671514171 |
GO:0030424 | axon | 0.0372856665626736 |
GO:0043025 | cell soma | 0.0376930235471054 |
GO:0007189 | G-protein signaling, adenylate cyclase activating pathway | 0.0377782978616244 |
GO:0007631 | feeding behavior | 0.0377782978616244 |
GO:0016020 | membrane | 0.0377782978616244 |
GO:0006937 | regulation of muscle contraction | 0.0377782978616244 |
GO:0006939 | smooth muscle contraction | 0.0377782978616244 |
GO:0045761 | regulation of adenylate cyclase activity | 0.0377782978616244 |
GO:0031279 | regulation of cyclase activity | 0.0377782978616244 |
GO:0035150 | regulation of tube size | 0.0377782978616244 |
GO:0050880 | regulation of blood vessel size | 0.0377782978616244 |
GO:0051339 | regulation of lyase activity | 0.0377782978616244 |
GO:0008016 | regulation of heart contraction | 0.0377782978616244 |
GO:0003018 | vascular process in circulatory system | 0.0381050662887932 |
GO:0008375 | acetylglucosaminyltransferase activity | 0.0382569587600429 |
GO:0009582 | detection of abiotic stimulus | 0.0382569587600429 |
GO:0050906 | detection of stimulus during sensory perception | 0.0382569587600429 |
GO:0003015 | heart process | 0.0382569587600429 |
GO:0044463 | cell projection part | 0.0382569587600429 |
GO:0060047 | heart contraction | 0.0382569587600429 |
GO:0009581 | detection of external stimulus | 0.0401438385172046 |
GO:0008217 | regulation of blood pressure | 0.0435547660791225 |
GO:0030133 | transport vesicle | 0.0492015448315908 |
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br><br>disease_data<br>
Ontology term | p-value | n |
---|---|---|
peptide hormone secreting cell | 1.23e-66 | 1 |
enteroendocrine cell | 1.23e-66 | 1 |
type D enteroendocrine cell | 1.23e-66 | 1 |
somatostatin secreting cell | 1.23e-66 | 1 |
pancreatic D cell | 1.23e-66 | 1 |
progenitor cell of endocrine pancreas | 1.23e-66 | 1 |
glandular epithelial cell | 1.04e-08 | 9 |
endocrine cell | 1.04e-08 | 9 |
Ontology term | p-value | n |
---|---|---|
somatostatinoma | 1.23e-66 | 1 |
lung small cell carcinoma | 1.03e-17 | 4 |
neuroendocrine tumor | 2.19e-12 | 6 |
bronchus cancer | 9.89e-11 | 7 |
bronchogenic carcinoma | 9.89e-11 | 7 |
lung carcinoma | 1.21e-08 | 9 |
neuroectodermal tumor | 5.73e-08 | 10 |
Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
MA0003.1 | 2.92366e-08 |
MA0004.1 | 0.059644 |
MA0006.1 | 0.0188876 |
MA0007.1 | 0.800602 |
MA0009.1 | 0.731476 |
MA0014.1 | 0.0112454 |
MA0017.1 | 0.385198 |
MA0019.1 | 0.192717 |
MA0024.1 | 0.068993 |
MA0025.1 | 0.183196 |
MA0027.1 | 1.47809 |
MA0028.1 | 0.00823259 |
MA0029.1 | 0.0761517 |
MA0030.1 | 1.89858 |
MA0031.1 | 3.30935 |
MA0038.1 | 0.0522657 |
MA0040.1 | 0.078397 |
MA0041.1 | 0.295713 |
MA0042.1 | 0.0518809 |
MA0043.1 | 0.732147 |
MA0046.1 | 0.348554 |
MA0048.1 | 0.879104 |
MA0050.1 | 0.122838 |
MA0051.1 | 0.138532 |
MA0052.1 | 0.0799011 |
MA0055.1 | 3.46397 |
MA0056.1 | 0 |
MA0057.1 | 0.100506 |
MA0058.1 | 0.106926 |
MA0059.1 | 0.0180581 |
MA0060.1 | 0.38269 |
MA0061.1 | 0.0416603 |
MA0063.1 | 0 |
MA0066.1 | 1.43766 |
MA0067.1 | 0.304116 |
MA0068.1 | 7.09603e-05 |
MA0069.1 | 0.700363 |
MA0070.1 | 0.677051 |
MA0071.1 | 0.225678 |
MA0072.1 | 0.667761 |
MA0073.1 | 0.314682 |
MA0074.1 | 1.40684 |
MA0076.1 | 0.127077 |
MA0077.1 | 1.08532 |
MA0078.1 | 1.13094 |
MA0081.1 | 0.192975 |
MA0083.1 | 0.371099 |
MA0084.1 | 0.448027 |
MA0087.1 | 0.32237 |
MA0088.1 | 0.561366 |
MA0089.1 | 0 |
MA0090.1 | 0.00771878 |
MA0091.1 | 2.31628 |
MA0092.1 | 0.982407 |
MA0093.1 | 0.0199133 |
MA0095.1 | 0 |
MA0098.1 | 0 |
MA0100.1 | 0.534027 |
MA0101.1 | 0.176497 |
MA0103.1 | 1.66607 |
MA0105.1 | 0.00408927 |
MA0106.1 | 0.913841 |
MA0107.1 | 0.0612513 |
MA0108.2 | 0.185137 |
MA0109.1 | 0 |
MA0111.1 | 0.289689 |
MA0113.1 | 0.207971 |
MA0114.1 | 0.250917 |
MA0115.1 | 0.251028 |
MA0116.1 | 0.032712 |
MA0117.1 | 0.130757 |
MA0119.1 | 0.412433 |
MA0122.1 | 0.443081 |
MA0124.1 | 0.223844 |
MA0125.1 | 0.172798 |
MA0130.1 | 0 |
MA0131.1 | 0.0282896 |
MA0132.1 | 0 |
MA0133.1 | 0 |
MA0135.1 | 0.127133 |
MA0136.1 | 0.150065 |
MA0139.1 | 0.0900265 |
MA0140.1 | 0.0359282 |
MA0141.1 | 0.103316 |
MA0142.1 | 0.160036 |
MA0143.1 | 0.20819 |
MA0144.1 | 0.0787341 |
MA0145.1 | 0.847926 |
MA0146.1 | 4.36987e-05 |
MA0147.1 | 0.000273782 |
MA0148.1 | 4.55701 |
MA0149.1 | 0.00598841 |
MA0062.2 | 0.0188104 |
MA0035.2 | 1.96299 |
MA0039.2 | 0.454775 |
MA0138.2 | 0.0248704 |
MA0002.2 | 0.230789 |
MA0137.2 | 0.123407 |
MA0104.2 | 0.00103717 |
MA0047.2 | 3.5947 |
MA0112.2 | 0.743124 |
MA0065.2 | 0.642209 |
MA0150.1 | 0.24544 |
MA0151.1 | 0 |
MA0152.1 | 0.0382624 |
MA0153.1 | 0.163249 |
MA0154.1 | 0.023977 |
MA0155.1 | 0.0669785 |
MA0156.1 | 0.674539 |
MA0157.1 | 2.29584 |
MA0158.1 | 0 |
MA0159.1 | 0.0698723 |
MA0160.1 | 0.190068 |
MA0161.1 | 0 |
MA0162.1 | 3.97932e-07 |
MA0163.1 | 0.00260989 |
MA0164.1 | 0.427436 |
MA0080.2 | 0.402771 |
MA0018.2 | 1.27739 |
MA0099.2 | 0.110132 |
MA0079.2 | 0.00022845 |
MA0102.2 | 0.478533 |
MA0258.1 | 0.653631 |
MA0259.1 | 0.323807 |
MA0442.1 | 0 |
ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data
(#promoters = Number of promoters in this coexpression cluster that have ChIP signal of the TF)
TF | #promoters | Enrichment | p-value | q-value |
---|---|---|---|---|
ESR1#2099 | 9 | 3.00997206158033 | 0.00309012297816625 | 0.0162871235789405 |
NR3C1#2908 | 13 | 2.11575329679619 | 0.00811830728409651 | 0.0320615577403576 |
Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data